<DOC>
	<DOCNO>NCT02103595</DOCNO>
	<brief_summary>German Multi-centered , randomize , crossover study diabetic patient evaluate two infusion set real life condition home . Subjects randomize use one infusion set device first period 4 week , switch infusion set second period 4 week .</brief_summary>
	<brief_title>A Study Evaluating Perception Insertion Pain With Accu-Chek FlexLink FlexLink Plus Insulin Pump Devices Under Real Life Conditions Diabetic Patients .</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Male female subject least 18 year age Diabetes mellitus type 1 type 2 Continuous subcutaneous insulin therapy ( CSII ) least 3 month Insulin pump compatible Luer lock infusion set ( AccuChek , Disetronic , Animas , Deltec Cozmo Minimed 506 508 ) Sufficient potential infusion site suitable usage cannula length 8 mm tube length 70 80 cm Willing measure blood glucose least 4 time per day 13 hr new insertion Willing able participate comply study procedure include general recommendation shift infusion set ( least every 3 day ) Significantly impaired awareness hypoglycemia A history high risk ketoacidosis CSII therapy Frequent catheter abscess past year , per investigator´s discretion Known strong plaster incompatibility and/or allergy ( history catheter use ) Unstable chronic disease diabetes Chronic use steroid adrenal suppressive dos , immunomodulatory medication chemotherapy Acute illness abnormality time screen render patient suitable participate study opinion Investigator Chronic use analgesic condition interfere assessment pain , per investigator´s discretion Are either pregnant breastfeeding currently plan pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>